CHAMPION: A Study to Evaluate the Efficacy and Safety of Obudanersen (ION582) in Children and Adults With Angelman Syndrome (AS)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The primary purpose of the study is to evaluate efficacy of obudanersen in participants with AS due to uniparental disomy or imprinting defects (UPD/ID) as measured through expressive communication.
Epistemonikos ID: bc1c63da727aa2b995d351a615a1965cd7a586b0
First added on: Aug 26, 2026